A small clinical trial testing whether a probiotic supplement could ease anxiety in people with Parkinson’s disease found that…
Marisa Wexler, MS
Marisa holds a Master of Science in cellular and molecular pathology from the University of Pittsburgh, where she studied novel genetic drivers of ovarian cancer. Her areas of expertise include cancer biology, immunology, and genetics, and she has worked as a science writing and communications intern for the Genetics Society of America.
At Bionews we’re committed to providing the most accurate, relevant, and up-to-date reporting for our patient communities. Our goal is to ensure that everyone has access to disease-specific information that is both trustworthy and easy to understand. You can read more about our editorial policy here.
Articles by Marisa Wexler, MS
Women with Parkinson’s disease are far less likely than men to undergo deep brain stimulation (DBS), in part…
People with Parkinson’s disease who switch from other levodopa/carbidopa formulations to Vyalev (foscarbidopa and foslevodopa) usually see uncontrolled…
People with Parkinson’s disease who switch from other formulations of levodopa to Crexont may experience improvements in daily…
Levodopa, the gold-standard treatment for Parkinson’s disease, is often given alongside medicines called catechol-O-methyltransferase inhibitors (COMT-Is) that are designed…
A new support group called Angels Embrace aims to offer education, connection, and emotional support for people affected by neurodegenerative…
In the U.S., the total cost of Parkinson’s disease — including direct medical costs and lost productivity from patients and…
Scientists have demonstrated that it is possible to collect individualized data on how connections among brain circuits change for people…
Scientists in Denmark are embarking on a three-year project aiming to develop a…
The first few participants in a clinical trial have reported notable easing of motor symptoms following treatment with Oryon Cell…